Belite Bio BLTE Income Statement (2020-2026)

NASDAQ BLTE
$187.12 +16.03 (+9.37%)
As of: Sep 4, 2026 · 12:49 PM EDT
Reported Financials

Belite Bio Quarterly Income Statement

Periods 18 quarters
Latest Jun 2026

Belite Bio reported net income of -$28.41M for the quarter ended Jun 2026. This income statement covers 18 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Dec2020 Dec2021 Jun2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity)Shares Outstanding (Entity.) 9.57M10.27M19.98M29.15M31.83M39.34M
Operating items
Research & DevelopmentR&D 1.58M5.23M5.72M55.168.74M4.86M6.76M9.08M6.84M72.549.40M11.05M10.31M146.2415.66M18.21M
Selling, General & AdministrativeSG&A 0.93M1.50M1.16M13.552.22M2.09M1.56M1.39M2.90M42.036.12M6.55M12.71M134.5317.02M16.69M
Operating ExpensesOpex 2.51M6.72M6.88M68.7110.96M6.96M8.33M10.47M9.74M114.5715.52M17.60M23.02M280.7732.68M34.91M
Operating IncomeOp. Inc -2.51M-6.72M-6.88M-68.71-10.96M-6.96M-8.33M-10.47M-9.74M-114.57-15.52M-17.60M-23.02M-280.77-32.68M-34.91M
EBIT -2.51M-6.72M-6.88M-68.71-10.96M-6.96M-8.33M-10.47M-9.74M-114.57-15.52M-17.60M-23.02M-280.77-32.68M-34.91M
Non-operating items
Non Operating Interest Expenses -0.48M-0.66M
Interest & Investment IncomeInt & Inv Inc 1.24M3.17M
Other Non Operating IncomeOther Non Op Inc. 0.14M-0.42M
Non Operating IncomeNon Op. Inc. 0.12M-0.06M-0.01M0.620.03M-0.04M0.46M0.98M1.06M13.571.24M1.28M1.33M27.535.75M6.55M
Net income details
EBT -2.39M-6.78M-6.89M-68.09-10.93M-6.99M-7.87M-9.49M-8.68M-101.00-14.28M-16.32M-21.69M-253.24-26.94M-28.36M
Tax ProvisionsTaxes 0.01M0.030.00M-0.00M0.01M0.06M
Profit After TaxPAT -2.39M-6.78M-6.89M-68.12-10.94M-6.99M-7.87M-9.49M-8.68M-101.00-14.28M-16.32M-21.69M-253.24-26.94M-28.41M
Income from Non-Controlling InterestsInc. Minority -4.21M-6.67M-7.62M41.49M-11.71M-13.20M-6.78M
Income from Continuing OperationsIncome (Continuing) -2.39M-6.78M-6.89M-68.12-10.94M-6.99M-7.87M-9.49M-8.68M-101.00-14.28M-16.32M-21.69M-253.24-26.94M-28.41M
Consolidated Net IncomeConsol Net Inc. -2.39M-6.78M-6.89M-68.12-10.94M-6.99M-7.87M-9.49M-8.68M-101.00-14.28M-16.32M-21.69M-253.24-26.94M-28.41M
Income towards Parent CompanyParent Net Inc -2.39M-6.78M-6.89M-68.12-10.94M-6.99M-7.87M-9.49M-8.68M-101.00-14.28M-16.32M-21.69M-253.24-26.94M-28.41M
Net Income towards Common StockholdersNet Income -2.39M-6.78M-6.89M-68.12-10.94M-6.99M-7.87M-9.49M-8.68M-101.00-14.28M-16.32M-21.69M-253.24-26.94M-28.41M
Additional items
EPS (Basic) -0.25-0.34-0.350.00-0.55-0.26-0.30-0.36-0.330.00-0.47-0.53-0.710.00-0.80-0.85
EPS (Diluted) -0.25-0.34-0.350.00-0.55-0.26-0.30-0.36-0.330.00-0.47-0.53-0.710.00-0.80-0.85
Shares Outstanding 8.79M9.57M9.57M19.98M19.98M19.98M19.98M26.59M26.59M26.59M26.59M30.54M30.54M30.54M30.54M33.54M33.54M33.54M
Shares Outstanding (Diluted)Shares Outstanding (Dil.) 8.79M9.57M9.57M19.98M19.98M19.98M19.98M26.59M26.59M26.59M26.59M30.54M30.54M30.54M30.54M33.54M33.54M33.54M
EBITDA -2.51M-6.72M-6.88M-68.71-10.96M-6.96M-8.33M-10.47M-9.74M-114.57-15.52M-17.60M-23.02M-280.77-32.68M-34.91M
Interest ExpensesInt Expense -0.48M-0.66M
Tax Rate -0.09-0.04-0.010.01-0.08-0.19